Laura Canas-Ruiz

Madrid, MD 28034, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cells.

Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cells.

Journal: Journal of biomedical science

Published: September 16, 2025

Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal Adenocarcinoma.

Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal Adenocarcinoma.

Journal: International journal of nanomedicine

Published: July 01, 2025

c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT.

c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT.

Journal: Molecular cancer

Published: March 10, 2025

Biocompatible self-illuminating sphingomyelin nanosystems for photodynamic-based cancer therapy.

Biocompatible self-illuminating sphingomyelin nanosystems for photodynamic-based cancer therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 28, 2025

c-Rel drives pancreatic cancer metastasis through Fibronectin-Integrin signaling-induced isolation stress resistance and EMT activation.

c-Rel drives pancreatic cancer metastasis through Fibronectin-Integrin signaling-induced isolation stress resistance and EMT activation.

Journal: bioRxiv : the preprint server for biology

Published: February 20, 2025

Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma.

Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma.

Journal: Cancer letters

Published: January 27, 2025

PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer.

PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer.

Journal: Cancer research

Published: September 24, 2024

Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis.

Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis.

Journal: Journal of nanobiotechnology

Published: May 15, 2024

Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.

Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 15, 2023

The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.

The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.

Journal: Gut

Published: August 25, 2023

Alx3 deficiency disrupts energy homeostasis, alters body composition, and impairs hypothalamic regulation of food intake.

Alx3 deficiency disrupts energy homeostasis, alters body composition, and impairs hypothalamic regulation of food intake.

Journal: Cellular and molecular life sciences : CMLS

Published: July 10, 2023

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue.

Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue.

Journal: Journal of visualized experiments : JoVE

Published: June 12, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026